Ironwood Pharmaceuticals annual gross margin
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Ironwood Pharmaceuticals Gross Margin Growth & History (IRWD)
Ironwood Pharmaceuticals's gross margin was 100.00% for fiscal 2022.
View full Ironwood Pharmaceuticals company overviewIronwood Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | 100.00% | 0.00 pp |
| 2021 | 2021-12-31 | 100.00% | +0.81 pp |
| 2020 | 2020-12-31 | 99.19% | +4.77 pp |
| 2019 | 2019-12-31 | 94.43% | +3.88 pp |
| 2018 | 2018-12-31 | 90.55% | −3.05 pp |
| 2017 | 2017-12-31 | 93.60% | −5.72 pp |
| 2016 | 2016-12-31 | 99.32% | −0.67 pp |
| 2015 | 2015-12-31 | 99.99% | +6.91 pp |
| 2014 | 2014-12-31 | 93.08% | +24.56 pp |
| 2013 | 2013-12-31 | 68.52% | −30.84 pp |
| 2012 | 2012-12-31 | 99.36% | — |
Ironwood Pharmaceuticals quarterly gross margin
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q1.15
Q2.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q4 2020 | 2020-12-31 | 99.23% | +7.95 pp |
| Q3 2020 | 2020-09-30 | 100.00% | +0.39 pp |
| Q2 2020 | 2020-06-30 | 100.00% | +11.07 pp |
| Q1 2020 | 2020-03-31 | 97.20% | −1.28 pp |
| Q4 2019 | 2019-12-31 | 91.28% | +7.70 pp |
| Q3 2019 | 2019-09-30 | 99.61% | +6.64 pp |
| Q2 2019 | 2019-06-30 | 88.93% | −6.06 pp |
| Q1 2019 | 2019-03-31 | 98.48% | +2.25 pp |
| Q4 2018 | 2018-12-31 | 83.58% | −6.89 pp |
| Q3 2018 | 2018-09-30 | 92.97% | −0.02 pp |
| Q2 2018 | 2018-06-30 | 94.99% | +0.37 pp |
| Q1 2018 | 2018-03-31 | 96.23% | −2.75 pp |
| Q4 2017 | 2017-12-31 | 90.46% | — |
| Q3 2017 | 2017-09-30 | 93.00% | — |
| Q2 2017 | 2017-06-30 | 94.62% | — |
| Q1 2017 | 2017-03-31 | 98.98% | — |
| Q2 2015 | 2015-06-30 | 70.62% | +124.40 pp |
| Q1 2015 | 2015-03-31 | 99.96% | +13.13 pp |
| Q2 2014 | 2014-06-30 | −53.77% | −118.40 pp |
| Q1 2014 | 2014-03-31 | 86.83% | +24.65 pp |
| Q4 2013 | 2013-12-31 | 89.41% | — |
| Q3 2013 | 2013-09-30 | 59.02% | — |
| Q2 2013 | 2013-06-30 | 64.63% | — |
| Q1 2013 | 2013-03-31 | 62.18% | — |
Ironwood Pharmaceuticals gross margin trends
Over the last five fiscal years, Ironwood Pharmaceuticals's gross margin increased from 93.60% to 100.00%, a change of +6.40 percentage points. The latest reported quarter, Q4 2020, shows 99.23%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ironwood Pharmaceuticals source filings ↗